Sugimoto Y - Search Results

1

Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.

Sugimoto Y, Suzuki H, Yamaki H, Nishimura T, Tanaka N. Sugimoto Y, et al. J Antibiot (Tokyo). 1982 Sep;35(9):1222-30. doi: 10.7164/antibiotics.35.1222. J Antibiot (Tokyo). 1982. PMID: 7142023 Free article.

2

Alteration of membrane-associated enzymes in drug-resistant sublines of mouse lymphoblastoma L5178Y cells.

Sugimoto Y, Nishimura T, Suzuki H, Tanaka N. Sugimoto Y, et al. J Antibiot (Tokyo). 1981 Sep;34(9):1200-5. doi: 10.7164/antibiotics.34.1200. J Antibiot (Tokyo). 1981. PMID: 6173369 Free article.

3

Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.

Suzuki H, Sugimoto Y, Tanaka K, Nishimura T, Tanaka N. Suzuki H, et al. Among authors: sugimoto y. J Antibiot (Tokyo). 1984 May;37(5):602-9. doi: 10.7164/antibiotics.37.602. J Antibiot (Tokyo). 1984. PMID: 6547433 Free article.

4

Evidence of altered influx of adriamycin into anthracycline-resistant cells.

Sugimoto Y, Nishimura T, Suzuki H, Tanaka N. Sugimoto Y, et al. J Antibiot (Tokyo). 1981 Aug;34(8):1064-6. doi: 10.7164/antibiotics.34.1064. J Antibiot (Tokyo). 1981. PMID: 6947975 Free article. No abstract available.

5

Alteration of plasma membrane of drug-resistant tumor cells: 230-kilodalton protein identified by monoclonal antibody.

Sugimoto Y, Suzuki H, Tanaka N. Sugimoto Y, et al. Biochem Biophys Res Commun. 1983 Aug 12;114(3):969-75. doi: 10.1016/0006-291x(83)90655-1. Biochem Biophys Res Commun. 1983. PMID: 6577861

6

Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.

Sugimoto Y, Hirakawa Y, Tanaka N, Tahara M, Sato I, Nishimura T, Suzuki H, Tanaka N. Sugimoto Y, et al. Cancer Res. 1986 Nov;46(11):5646-8. Cancer Res. 1986. PMID: 3463416

7

Mechanism of action of a new macromolecular antitumor antibiotic, C-1027.

Sugimoto Y, Otani T, Oie S, Wierzba K, Yamada Y. Sugimoto Y, et al. J Antibiot (Tokyo). 1990 Apr;43(4):417-21. doi: 10.7164/antibiotics.43.417. J Antibiot (Tokyo). 1990. PMID: 2161819 Free article.

8

Novel regulatory role for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP in chemosensitization to bleomycin.

Masuda Y, Noguchi K, Segawa H, Tanaka N, Katayama K, Mitsuhashi J, Sugimoto Y. Masuda Y, et al. Among authors: sugimoto y. Biochem Biophys Res Commun. 2011 Nov 18;415(2):305-12. doi: 10.1016/j.bbrc.2011.10.050. Epub 2011 Oct 21. Biochem Biophys Res Commun. 2011. PMID: 22037577

9

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.

Mashima T, Taneda Y, Jang MK, Mizutani A, Muramatsu Y, Yoshida H, Sato A, Tanaka N, Sugimoto Y, Seimiya H. Mashima T, et al. Among authors: sugimoto y. Oncotarget. 2017 Jul 18;8(29):47902-47915. doi: 10.18632/oncotarget.18146. Oncotarget. 2017. PMID: 28615517 Free PMC article.

10

Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells.

Nonomiya Y, Noguchi K, Tanaka N, Kasagaki T, Katayama K, Sugimoto Y. Nonomiya Y, et al. Among authors: sugimoto y. Cancer Sci. 2016 Dec;107(12):1877-1887. doi: 10.1111/cas.13093. Epub 2016 Dec 19. Cancer Sci. 2016. PMID: 27699933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,687 results

Search Page

Filters